2020-21 SCID blood spot (pilot)

Scheme description
Molecular testing of newborn screening cards for TREC levels associated with Severe Combined Immunodeficiency (SCID).
Disorders/Gene target(s)
T-cell receptor excision circles (TRECs)
Clinical cases
Eight (four per distribution).
Testing/analysis
Index case only.
Test for number of TRECs.
Sample type
Newborn screening card
Techniques
Any methodology.
Assessment
Submit a proforma to include:
• TREC levels
Performance criteria are NOT applied.
Eligibility
All laboratories worldwide.
Languages
English
ISO17043 Accredited EQA
No
EQA timeline
Sample dispatchPostponed until January 2021
Testing period4 weeks
Assessment resultsTBC
Final Summary reportTBC
Other information
Fee
£260.00
GenQA code
2020SCIDBS1
« Return to EQA scheme list
Go to top